Glucos B. Braun (Glucose Monohydrate)

Glucos B. Braun is primarily employed as an intravenous carbohydrate source in clinical settings.

• Provide supplemental calories for patients unable to receive oral nutrition.
• Maintain blood glucose levels during fasting or surgical procedures.
• Serve as a diluent for compatible intravenous medications.
• Assist in correcting mild hypoglycemia when rapid glucose delivery is required.
• Contribute to fluid replacement in combination with electrolytes.

Adverse reactions to Glucos B. Braun are generally related to the intravenous administration of a glucose solution and may vary in frequency and severity.

Common

• Mild hyperglycemia, especially in patients with impaired glucose tolerance.
• Local irritation at the infusion site.
• Nausea or vomiting if administered rapidly.
• Transient electrolyte shifts, such as mild hyponatremia.
• Blood sugar spikes causing temporary fatigue.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic reactions ranging from urticaria to anaphylaxis.
• Volume overload in patients with compromised cardiac function.
• Hyperosmolar coma in uncontrolled diabetes.

When using Glucos B. Braun, clinicians should observe several precautions to ensure patient safety and appropriate therapeutic effect.

• Assess baseline blood glucose and monitor levels during infusion.
• Adjust infusion rate in patients with renal or cardiac insufficiency to avoid fluid overload.
• Avoid use in individuals with known hypersensitivity to glucose solutions.
• Consider alternative carbohydrate sources for patients with severe hyperglycemia or diabetic ketoacidosis.
• Verify compatibility with other intravenous drugs before mixing.
• Store the solution according to manufacturer guidelines to maintain sterility.

Glucose solutions can interact with other intravenously administered agents, influencing efficacy or safety.

Avoid

• Co‑administration with high‑dose insulin infusions without appropriate glucose monitoring.
• Mixing with calcium‑containing solutions that may precipitate.
• Simultaneous infusion of hypertonic saline that could exacerbate hyperglycemia.
• Concurrent infusion with potassium chloride solutions, which may cause precipitation.

Use with caution

• Concurrent use of diuretics, which may affect fluid balance and electrolyte status.
• Administration alongside beta‑blockers, as they can mask signs of hypoglycemia.
• Combining with catecholamines, which may increase glucose production and alter glycemic control.
• Use with caution when patients are receiving glucocorticoids, as they can raise blood glucose.